ATryn from transgenic goats launched in the US
This article was originally published in Scrip
Executive Summary
Lundbeck has launched the recombinant antithrombin product, ATryn, in the US, the first medicine to be manufactured in transgenic animals – goats. ATryn was approved in the US in February.